The Chemours Company
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|
| Revenue | $6.18B | $5.40B | $5.72B | $6.43B | $6.86B |
| Cost of Revenue | $4.44B | $4.30B | $4.76B | $5.07B | $5.40B |
| Gross Profit | $1.75B | $1.10B | $955.0M | $1.36B | $1.46B |
| Gross Margin | 28.2% | 20.4% | 16.7% | 21.1% | 21.3% |
| Operating Expenses | |||||
| Research & Development | $81.0M | $81.0M | $97.0M | $143.0M | $164.0M |
| SG&A Expense | $626.0M | $946.0M | $632.0M | $685.0M | $768.0M |
| Operating Income | $1.13B | $208.0M | $-56.0M | $550.0M | $576.0M |
| Operating Margin | 18.2% | 3.9% | -1.0% | 8.6% | 8.4% |
| Interest Expense | $214.0M | $219.0M | $132.0M | $0 | $0 |
| Pretax Income | $912.0M | $-11.0M | $-188.0M | $550.0M | $576.0M |
| Income Tax Expense | $165.0M | $-18.0M | $-98.0M | $149.0M | $152.0M |
| Net Income | $746.0M | $7.0M | $-90.0M | $400.0M | $423.0M |
| Net Margin | 12.1% | 0.1% | -1.6% | 6.2% | 6.2% |
| EPS (Basic) | $4.04 | $0.04 | $-0.50 | $2.21 | $2.34 |
| EPS (Diluted) | $3.91 | $0.04 | $-0.50 | $2.21 | $2.34 |
| Shares Outstanding (Basic) | 184.8M | 181.6M | 181.0M | 181.0M | 181.0M |
| Shares Outstanding (Diluted) | 191.0M | 183.4M | 181.0M | 181.0M | 181.0M |
| Dividends Per Share | $0.29 | $0.12 | $0.58 | $0.00 | — |